Identification of 779 Genetic Variations in Eight Genes Encoding Members

Total Page:16

File Type:pdf, Size:1020Kb

Identification of 779 Genetic Variations in Eight Genes Encoding Members B.J Hum Jochimsen Genet et(2002) al.: Stetteria 47:147–171 hydrogenophila © Jpn Soc Hum Genet and Springer-Verlag4600/147 2002 ORIGINAL ARTICLE Susumu Saito · Aritoshi Iida · Akihiro Sekine Yukie Miura · Chie Ogawa · Saori Kawauchi Shoko Higuchi · Yusuke Nakamura Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR) Received: January 8, 2002 / Accepted: January 9, 2002 Abstract We screened DNAs from 48 Japanese individuals ac.uk/nomenclature/genefamily/abc.html]). Members of the for single-nucleotide polymorphisms (SNPs) in eight genes MRP/CFTR family have been recognized as export pumps encoding the ATP-binding cassette, subfamily C (ABCC/ for amphiphilic anions, particularly for conjugates of lipo- MRP/CFTR), by direct sequencing of their entire genomic philic compounds with glutathione or several other anionic regions, except repetitive sequence elements. This ap- residues (Keppler et al. 1998, 1999; König et al. 1999). proach identified 688 SNPs and 91 insertion/deletion ABCC1 (MRP1) has been found to be overexpressed in polymorphisms among the eight genes. Of the 688 SNPs, many drug-resistant cell lines and tumor tissues (Cole et al. 81 were identified in the ABCC1 gene, 41 in ABCC2, 30 in 1992; Loe et al. 1996). When being overexpressed in tumor ABCC3, 230 in ABCC4, 76 in ABCC5, 58 in CFTR, 102 in cells, ABCC1 confers multidrug resistance by reducing ABCC8, and 70 in ABCC9. Six SNPs were located in the intracellular drug concentrations in an ATP-dependent 5Ј flanking regions, 617 in introns, 46 in exons, and 19 in the manner (Cole et al. 1994; Zaman et al. 1994). ABCC1 is 3Ј flanking regions. These variants should contribute to ubiquitously expressed, but at a very low expression level in studies that investigate possible correlations of genotypes the liver (Stride et al. 1996). This protein serves as an efflux with disease-susceptibility phenotypes and responsiveness pump for xenobiotics, drugs, and cellular metabolites or adverse effects to drugs. (König et al. 1999). In the brain, ABCC1 together with ABCB1 (MDR1) forms part of the blood-brain barrier Key words Single-nucleotide polymorphism (SNP) · ATP- (Rao et al. 1999). Although various polymorphisms have binding cassette, subfamily C (ABCC) · Multidrug resis- been reported in the ABCC1 gene, their phenotypic conse- tance protein (MRP) · Cystic fibrosis transmembrane quences have not been observed (Perdu and Germain 2000; conductance regulator (CFTR) · Sulfonylurea receptor Conrad et al. 2001; Ito et al. 2001). (SUR) ABCC2 (MRP2) is mainly expressed in the canalicular membrane of hepatocytes (Kool et al. 1997). Its major physiological function is the secretion of bilirubin glucu- Introduction ronides and organic anions into bile (Jedlitschky et al. 1997). ABCC2 also confers resistance to multiple anti- cancer chemotherapeutic agents when it is overexpressed in Multidrug resistance protein/cystic fibrosis transmembrane tumor cells (Cui et al. 1999). Mutations in the ABCC2 conductance regulator (MRP/CFTR) constitutes a subfam- gene were reported to cause Dubin-Johnson syndrome ily of ATP-binding cassette (ABC) proteins (Human ABC (Kartenbeck et al. 1996; Paulusma et al. 1997; Toh et al. Gene Nomenclature Committee [http://www.gene.ucl. 1999). By screening an expressed sequence tag (EST) database, ABCC3 (MRP3), ABCC4 (MRP4), and ABCC5 (MRP5) were identified (Kool et al. 1997). ABCC3 is mainly ex- S. Saito · A. Iida · A. Sekine · Y. Miura · C. Ogawa · S. Kawauchi · S. Higuchi · Y. Nakamura pressed in liver, colon, intestine, and adrenal gland (Kool Laboratory for Genotyping, SNP Research Center, Institute of et al. 1997) and plays an important role in the removal of Physical and Chemical Research, Tokyo, Japan toxic organic anions from the liver under cholestatic condi- Y. Nakamura (*) tions (Kool et al. 1999). ABCC4 is widely expressed in Laboratory of Molecular Medicine, Human Genome Center, human tissues and predominantly in the prostate (Lee et al. Institute of Medical Science, The University of Tokyo, 4-6-1 1998), and its overexpression was shown to be correlated Shirokanedai, Minato-ku, Tokyo 108-8639, Japan Tel. ϩ81-3-5449-5372; Fax ϩ81-3-5449-5433 with ATP-dependent efflux of acyclic nucleoside mono- e-mail: [email protected] phosphates such as 9-(2-phosphonylmethoxyethyl) guanine 148 and the anti-human immunodeficiency virus (HIV) drug 9- in cardiac and skeletal muscle, whereas the SUR2B tran- (2-phosphonylmethoxyethyl)adenine (PMEA) (Schuetz et script was detected mainly in vascular smooth muscle al. 1999). Consequently, ABCC4 confers resistance to these (Isomoto et al. 1996; Davis-Taber et al. 2000). drugs. ABCC5 is mainly expressed at high transcript levels To investigate the nature of apparent genotype/ in skeletal muscle, brain, and heart, and at a very low level phenotype correlations for some ABC-transporters in more in liver (McAleer et al. 1999). This protein acts as the cellu- detail, we began by searching for additional single- lar export of cyclic nucleotides and introduces resistance nucleotide polymorphisms (SNPs) in the eight ABCC genes to thiopurine anticancer drugs such as 6-mercaptopurine described earlier, including their promoter regions and in- and thioguanine, and the anti-HIV drug PMEA (Wijnholds trons, except repetitive elements. We report here a total of et al. 2000). 779 genetic variations, of which 454 have not been reported CFTR (cystic fibrosis transmembrane conductance regu- before. lator) acts as a chloride channel (Bear et al. 1992) and also regulates other ion transport pathways including the amiloride-sensitive epithelial sodium channel (Schreiber et al. 1999). Mutations in the CFTR gene were found in Subjects and methods patients with cystic fibrosis (Cystic Fibrosis Mutation Data Base [http://www.genet.sickkids.on.ca/cftr/]) and congenital Total genomic DNAs were isolated from peripheral leuko- bilateral absence of the vas deferens (Costes et al. 1995; cytes by the standard phenol/chloroform extraction method Zielenski et al. 1995). CFTR mutations were found at sig- in 48 unrelated Japanese individuals. Informed consent was nificantly higher frequencies in patients with disseminated obtained from each participant. On the basis of sequence bronchiectasis or allergic bronchopulmonary aspergillosis information from GenBank, we designed polymerase than expected (Miller et al. 1996; Pignatti et al. 1996). chain reaction (PCR) primers to amplify DNA fragments The sulfonylurea receptor (SUR) contains ATP-sensi- from all eight genes, excluding repetitive elements, by tive potassium (K ) channels (Aguilar-Bryan et al. 1995) ATP invoking the REPEAT MASKER computer program that are involved in many diverse functions such as insulin (http://ftp.genome.washington.edu/cgi-bin/RepeatMasker). secretion from pancreatic cells, regulation of skeletal PCR experiments and DNA sequencing were performed muscle excitability, neurotransmitter release, and smooth according to methods described previously (Iida et al. 2001; muscle relaxation (Quayle et al. 1997). The SUR subunit Sekine et al. 2001; Saito et al. 2001). All SNPs detected by consists of two members, ABCC8 (SUR1) and ABCC9 the PolyPhred Computer Program (Nickerson et al. 1997) (SUR2). Channels containing isoform ABCC8 (SUR1) were confirmed by sequencing both strands of each PCR found in neuronal cells and pancreatic -cells are closed in product. response to the sulfonylurea hypoglycemic drugs (Gribble et al. 1998) and can be activated by diazoxide (D’hahan et al. 1999). Mutations and deficiencies in this protein were detected in patients with hyperinsulinemic hypoglyce- mia of infancy, an autosomal recessive disorder of unregu- Results lated and high insulin secretion (Thomas et al. 1995; Nestorowicz et al. 1996, 1998; Glaser et al. 1999; Verkarre Exon–intron boundaries of the eight genes were defined by et al. 1998). An arginine residue at codon 1273 was reported comparison of genomic sequences with cDNA sequences. to be associated with hyperinsulinemia in Mexican Accession numbers of the genomic and cDNA sequences American nondiabetic individuals (Goksel et al. 1998) and used for this study are listed in Table 1. We screened 96 with type 2 diabetes mellitus in French Caucasians (Reis et Japanese chromosomes for SNPs in the eight ABCC genes al. 2000). ABCC9 (SUR2) is the primary regulatory subunit by means of direct DNA sequencing. Figure 1 (a–h) illus- expressed in muscle cells and generates two splice variants, trates the location of each variation in the respective genes; SUR2A (exon 38a) and SUR2B (exon 38b) (Isomoto et al. detailed information for nucleotide positions and substitu- 1996). The SUR2A transcript was predominantly expressed tions is summarized in Table 2 (a–h). Table 1. Accession numbers for the genomic and cDNA sequences used in this study Accession number Gene name Chromosomal localization Genomic sequence cDNA sequence ABCC1 16p13.1 AC026452.5 AC025778.4 NM_004996.2 ABCC2 10q24 AL392107.4 U49248.1 ABCC3 17q22 AC004590.1 AC005921.3 NM_003786.2 ABCC4 13q32 AL356257.11 AL157818.12 AL139381.12 NM_005845.1 ABCC5 3q27 AC068644.5 NM_005688.1 CFTR 7q31.2 AC000111.1 AC000061.1 XM_004980.1 ABCC8 11p15.1 AC000406.1 NM000352.2 ABCC9 12p12.1 AC084806.9 AC008250.23 NM_005691.1 149 Fig. 1a–h. Locations of single-nucleotide polymorphisms (SNPs) in of repetitive elements. ATG, and TGA or TAA, initiation and stop ABCC1 (a), ABCC2 (b), ABCC3 (c), ABCC4 (d), ABCC5 (e), CFTR codons, respectively; ABCC, ATP-binding
Recommended publications
  • Multidrug Transporter MRP4/ABCC4 As a Key Determinant of Pancreatic
    www.nature.com/scientificreports OPEN Multidrug transporter MRP4/ ABCC4 as a key determinant of pancreatic cancer aggressiveness A. Sahores1, A. Carozzo1, M. May1, N. Gómez1, N. Di Siervi1, M. De Sousa Serro1, A. Yanef1, A. Rodríguez‑González2, M. Abba3, C. Shayo2 & C. Davio1* Recent fndings show that MRP4 is critical for pancreatic ductal adenocarcinoma (PDAC) cell proliferation. Nevertheless, the signifcance of MRP4 protein levels and function in PDAC progression is still unclear. The aim of this study was to determine the role of MRP4 in PDAC tumor aggressiveness. Bioinformatic studies revealed that PDAC samples show higher MRP4 transcript levels compared to normal adjacent pancreatic tissue and circulating tumor cells express higher levels of MRP4 than primary tumors. Also, high levels of MRP4 are typical of high-grade PDAC cell lines and associate with an epithelial-mesenchymal phenotype. Moreover, PDAC patients with high levels of MRP4 depict dysregulation of pathways associated with migration, chemotaxis and cell adhesion. Silencing MRP4 in PANC1 cells reduced tumorigenicity and tumor growth and impaired cell migration. Transcriptomic analysis revealed that MRP4 silencing alters PANC1 gene expression, mainly dysregulating pathways related to cell-to-cell interactions and focal adhesion. Contrarily, MRP4 overexpression signifcantly increased BxPC-3 growth rate, produced a switch in the expression of EMT markers, and enhanced experimental metastatic incidence. Altogether, our results indicate that MRP4 is associated with a more aggressive phenotype in PDAC, boosting pancreatic tumorigenesis and metastatic capacity, which could fnally determine a fast tumor progression in PDAC patients. Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies, due to its late diag- nosis, inherent resistance to treatment and early dissemination 1.
    [Show full text]
  • ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters Yu Fukuda University of Tennessee Health Science Center
    University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 12-2008 ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters Yu Fukuda University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Chemicals and Drugs Commons, and the Medical Sciences Commons Recommended Citation Fukuda, Yu , "ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters" (2008). Theses and Dissertations (ETD). Paper 345. http://dx.doi.org/10.21007/etd.cghs.2008.0100. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. ABCB6 Is a Porphyrin Transporter with a Novel Trafficking Signal That Is Conserved in Other ABC Transporters Document Type Dissertation Degree Name Doctor of Philosophy (PhD) Program Interdisciplinary Program Research Advisor John D. Schuetz, Ph.D. Committee Linda Hendershot, Ph.D. James I. Morgan, Ph.D. Anjaparavanda P. Naren, Ph.D. Jie Zheng, Ph.D. DOI 10.21007/etd.cghs.2008.0100 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/345 ABCB6 IS A PORPHYRIN TRANSPORTER WITH A NOVEL TRAFFICKING SIGNAL THAT
    [Show full text]
  • WO 2013/043130 Al 28 March 2013 (28.03.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/043130 Al 28 March 2013 (28.03.2013) P O P C T (51) International Patent Classification: Building Level 5, Singapore 16875 1 (SG). KHOR, Chiea- C12Q 1/68 (2006.01) Chuen; Genome Institute of Singapore, 60 Biopolis Street, Genome, Singapore 138672 (SG). (21) International Application Number: PCT/SG2012/00035 1 (74) Agent: CHUNG, Jing Yeng; Marks & Clerk Singapore LLP, Tanjong Pagar, P.O Box 636, Singapore 9108 16 (22) International Filing Date: (SG). 24 September 2012 (24.09.2012) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (30) Priority Data: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, 61/537,904 22 September 201 1 (22.09.201 1) US HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (71) Applicants: SINGAPORE HEALTH SERVICES PTE KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, LTD [SG/SG]; 31 Third Hospital Avenue, #03-03 Bowyer ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, Block C, Singapore 168753 (SG). AGENCY FOR SCI¬ NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, ENCE, TECHNOLOGY AND RESEARCH [SG/SG]; 1 RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, Fusionopolis Way, #20-10 Connexis, Singapore 138632 TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (SG).
    [Show full text]
  • Functional Studies on the MRP1 Multidrug Transporter: Characterization of ABC-Signature Mutant Variants
    ANTICANCER RESEARCH 24: 449-456 (2004) Functional Studies on the MRP1 Multidrug Transporter: Characterization of ABC-signature Mutant Variants ZS. SZENTPÉTERY1,2, B. SARKADI1, É. BAKOS2 and A. VÁRADI2 1National Medical Center, Institute of Haematology and Immunology, Membrane Research Group of the Hungarian Academy of Sciences, Budapest; 2Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, Hungary Abstract. Background: MRP1 is a key multidrug resistance these agents below the cell-killing threshold, thus conferring ATP-binding Cassette (ABC) transporter in tumor cells. A resistance to many structurally dissimilar anticancer drugs. functionally important signature motif is conserved within all One of the proteins causing this phenotype is the human ABC domains. Our current studies aimed to elucidate the role Multidrug Resistance Protein (MRP1), which confers of these motifs in the cooperation of MRP1 ABC domains. resistance to a wide variety of anticancer drugs (1), but has Materials and Methods: We designed human MRP1 mutants also been shown to be a high affinity primary active based on a bacterial ABC structure. Conserved leucines (Leu) transporter for glutathione (GS)-conjugates (e.g. LTC4 – see were replaced by arginines (Arg), while glycines (Gly) were 2, 3). MRP1 transports large hydrophobic drugs, playing an substituted for aspartic acids (Asp). The activity of these important role in the chemotherapy resistance of several mutants was assayed by measuring ATPase activity and types of cancer cells, and cellular GS seem to be an vesicular transport. ATP-binding and transition-state formation important modulator in these transport functions (2, 4-9). were studied by a photoreactive ATP analog.
    [Show full text]
  • Inhibiting ABCG2 with Sorafenib
    Published OnlineFirst May 16, 2012; DOI: 10.1158/1535-7163.MCT-12-0215 Molecular Cancer Therapeutic Discovery Therapeutics New Use for an Old Drug: Inhibiting ABCG2 with Sorafenib Yinxiang Wei1,3, Yuanfang Ma3, Qing Zhao1,4, Zhiguang Ren1,3, Yan Li1, Tingjun Hou2, and Hui Peng1 Abstract Human ABCG2, a member of the ATP-binding cassette transporter superfamily, represents a promising target for sensitizing MDR in cancer chemotherapy. Although lots of ABCG2 inhibitors were identified, none of them has been tested clinically, maybe because of several problems such as toxicity or safety and pharma- cokinetic uncertainty of compounds with novel chemical structures. One efficient solution is to rediscover new uses for existing drugs with known pharmacokinetics and safety profiles. Here, we found the new use for sorafenib, which has a dual-mode action by inducing ABCG2 degradation in lysosome in addition to inhibiting its function. Previously, we reported some novel dual-acting ABCG2 inhibitors that showed closer similarity to degradation-induced mechanism of action. On the basis of these ABCG2 inhibitors with diverse chemical structures, we developed a pharmacophore model for identifying the critical pharmacophore features necessary for dual-acting ABCG2 inhibitors. Sorafenib forms impressive alignment with the pharmacophore hypothesis, supporting the argument that sorafenib is a potential ABCG2 inhibitor. This is the first article that sorafenib may be a good candidate for chemosensitizing agent targeting ABCG2-mediated MDR. This study may facilitate the rediscovery of new functions of structurally diverse old drugs and provide a more effective and safe way of sensitizing MDR in cancer chemotherapy. Mol Cancer Ther; 11(8); 1693–702.
    [Show full text]
  • Developmental Differences in the Expression of ABC Transporters at Rat Brain Barrier Interfaces Following Chronic Exposure to Di
    www.nature.com/scientificreports OPEN Developmental diferences in the expression of ABC transporters at rat brain barrier interfaces Received: 28 November 2018 Accepted: 28 March 2019 following chronic exposure to Published: xx xx xxxx diallyl sulfde Liam M. Koehn1, Katarzyna M. Dziegielewska1, Kjeld Møllgård 2, Elodie Saudrais3, Nathalie Strazielle3,4, Jean-Francois Ghersi-Egea3, Norman R. Saunders 1 & Mark D. Habgood1 Many pregnant women and prematurely born infants require medication for clinical conditions including cancer, cardiac defects and psychiatric disorders. In adults drug transfer from blood into brain is mostly restricted by efux mechanisms (ATP-binding cassette, ABC transporters). These mechanisms have been little studied during brain development. Here expression of eight ABC transporters (abcb1a, abcb1b, abcg2, abcc1, abcc2, abcc3, abcc4, abcc5) and activity of conjugating enzyme glutathione-s- transferase (GST) were measured in livers, brain cortices (blood-brain-barrier) and choroid plexuses (blood-cerebrospinal fuid, CSF, barrier) during postnatal rat development. Controls were compared to animals chronically injected (4 days, 200 mg/kg/day) with known abcb1a inducer diallyl sulfde (DAS). Results reveal both tissue- and age-dependent regulation. In liver abcb1a and abcc3 were up- regulated at all ages. In cortex abcb1a/b, abcg2 and abcc4/abcc5 were up-regulated in adults only, while in choroid plexus abcb1a and abcc2 were up-regulated only at P14. DAS treatment increased GST activity in livers, but not in cortex or choroid plexuses. Immunocytochemistry of ABC transporters at the CSF-brain interface showed that PGP and BCRP predominated in neuroepithelium while MRP2/4/5 were prominent in adult ependyma. These results indicate an age-related capacity of brain barriers to dynamically regulate their defence mechanisms when chronically challenged by xenobiotic compounds.
    [Show full text]
  • Bile Acid Transporters and Regulatory Nuclear Receptors in the Liver and Beyond
    Review Bile acid transporters and regulatory nuclear receptors in the liver and beyond ⇑ Emina Halilbasic, Thierry Claudel, Michael Trauner Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Austria Summary logical functions including stimulation of bile flow, intestinal absorption of lipophilic nutrients, solubilization and excretion of Bile acid (BA) transporters are critical for maintenance of the enter- cholesterol, as well as antimicrobial and metabolic effects. Tight ohepatic BA circulation where BAs exert their multiple physio- regulation of BA transporters via nuclear receptors is necessary to maintain proper BA homeostasis. Hereditary and acquired defects of BA transporters are involved in the pathogenesis of sev- Keywords: Bile acids, Cholestasis; Fatty liver disease; Gallstones; Liver regener- eral hepatobiliary disorders including cholestasis, gallstones, fatty ation; Liver cancer. liver disease and liver cancer, but also play a role in intestinal and Received 12 January 2012; received in revised form 1 August 2012; accepted 3 August metabolic disorders beyond the liver. Thus, pharmacological mod- 2012 ification of BA transporters and their regulatory nuclear receptors ⇑ Corresponding author. Address: Hans Popper Laboratory of Molecular Hepa- tology, Division of Gastroenterology and Hepatology, Department of Internal opens novel treatment strategies for a wide range of disorders. Medicine III, Medical University of Vienna, Waehringer Waehringer Guertel 18- Ó 2012 European Association for the Study of the Liver. Published 20, A-1090 Vienna, Austria. Tel.: +43 01 40400 4741; fax: +43 01 40400 4735. by Elsevier B.V. All rights reserved. E-mail address: [email protected] (M. Trauner).
    [Show full text]
  • Transcriptional and Post-Transcriptional Regulation of ATP-Binding Cassette Transporter Expression
    Transcriptional and Post-transcriptional Regulation of ATP-binding Cassette Transporter Expression by Aparna Chhibber DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Pharmaceutical Sciences and Pbarmacogenomies in the Copyright 2014 by Aparna Chhibber ii Acknowledgements First and foremost, I would like to thank my advisor, Dr. Deanna Kroetz. More than just a research advisor, Deanna has clearly made it a priority to guide her students to become better scientists, and I am grateful for the countless hours she has spent editing papers, developing presentations, discussing research, and so much more. I would not have made it this far without her support and guidance. My thesis committee has provided valuable advice through the years. Dr. Nadav Ahituv in particular has been a source of support from my first year in the graduate program as my academic advisor, qualifying exam committee chair, and finally thesis committee member. Dr. Kathy Giacomini graciously stepped in as a member of my thesis committee in my 3rd year, and Dr. Steven Brenner provided valuable input as thesis committee member in my 2nd year. My labmates over the past five years have been incredible colleagues and friends. Dr. Svetlana Markova first welcomed me into the lab and taught me numerous laboratory techniques, and has always been willing to act as a sounding board. Michael Martin has been my partner-in-crime in the lab from the beginning, and has made my days in lab fly by. Dr. Yingmei Lui has made the lab run smoothly, and has always been willing to jump in to help me at a moment’s notice.
    [Show full text]
  • Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type Or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4
    Article Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4 Megumi Tsukamoto 1, Shiori Sato 2, Kazuhiro Satake 1, Mizuki Miyake 1 and Hiroshi Nakagawa 2,* 1 Department of Applied Biological Chemistry, Graduate School of Bioscience and Biotechnology, Chubu University, 1200 Matsumoto-cho, Kasugai 487-8501, Japan; [email protected] (M.T.); [email protected] (K.S.); [email protected] (M.M.) 2 Department of Applied Biological Chemistry, College of Bioscience and Biotechnology, Chubu University, 1200 Matsumoto-cho, Kasugai, Aichi 487-8501, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-568-51-9606; Fax: +81-568-52-6594 Received: 14 April 2017; Accepted: 26 June 2017; Published: 4 July 2017 Abstract: Broad-spectrum resistance in cancer cells is often caused by the overexpression of ABC transporters; which varies across individuals because of genetic single-nucleotide polymorphisms (SNPs). In the present study; we focused on human ABCC4 and established cells expressing the wild-type (WT) or SNP variants of human ABCC4 using the Flp-In™ system (Invitrogen, Life Technologies Corp, Carlsbad, CA, USA) based on Flp recombinase-mediated transfection to quantitatively evaluate the effects of nonsynonymous SNPs on the drug resistance profiles of cells. The mRNA levels of the cells expressing each ABCC4 variant were comparable. 3-(4,5-Dimethyl-2- thiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay clearly indicated that the EC50 values of azathioprine against cells expressing ABCC4 (WT) were 1.4–1.7-fold higher than those against cells expressing SNP variants of ABCC4 (M184K; N297S; K304N or E757K).
    [Show full text]
  • Computational Modeling to Predict the Functions and Impact of Drug Transporters Pär Matsson1,2* and Christel a S Bergström1,2*
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Matsson and Bergström In Silico Pharmacology (2015) 3:8 DOI 10.1186/s40203-015-0012-3 REVIEW Open Access Computational modeling to predict the functions and impact of drug transporters Pär Matsson1,2* and Christel A S Bergström1,2* Abstract Transport proteins are important mediators of cellular drug influx and efflux and play crucial roles in drug distribution, disposition and clearance. Drug-drug interactions have increasingly been found to occur at the transporter level and, hence, computational tools for studying drug-transporter interactions have gained in interest. In this short review, we present the most important transport proteins for drug influx and efflux. Computational tools for predicting and understanding the substrate and inhibitor interactions with these membrane-bound proteins are discussed. We have primarily focused on ligand-based and structure-based modeling, for which the state-of-the-art and future challenges are also discussed. Keywords: Drug transport; Membrane transporter; Carrier-mediated transport; Structure-activity relationship; Ligand-based modeling; Structure-based modeling Introduction Export Pump (BSEP; ABCB11), and the members of the Transport proteins, which are expressed in all tissues of multidrug resistance-associated protein family (MRP; the body, facilitate the transmembrane transport of essen- ABCC) (Giacomini et al. 2010, Hillgren et al. 2013). tial solutes such as nutrients and signal substances. They About 40 human ABC transporters are known to also play an important role in the removal of metabolites date, while more than 350 SLC transporters have been and toxicants from cells and tissues.
    [Show full text]
  • Interindividual Differences in the Expression of ATP-Binding
    Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2018/02/02/dmd.117.079061.DC1 1521-009X/46/5/628–635$35.00 https://doi.org/10.1124/dmd.117.079061 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 46:628–635, May 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction Interindividual Differences in the Expression of ATP-Binding Cassette and Solute Carrier Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human ABCC3 Gene s Tomoki Takechi, Takeshi Hirota, Tatsuya Sakai, Natsumi Maeda, Daisuke Kobayashi, and Ichiro Ieiri Downloaded from Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan (T.T., T.H., T.S., N.M., I.I.); Drug Development Research Laboratories, Kyoto R&D Center, Maruho Co., Ltd., Kyoto, Japan (T.T.); and Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan (D.K.) Received October 19, 2017; accepted January 30, 2018 dmd.aspetjournals.org ABSTRACT The identification of drug transporters expressed in human skin and levels. ABCC3 expression levels negatively correlated with the methylation interindividual differences in gene expression is important for understanding status of the CpG island (CGI) located approximately 10 kilobase pairs the role of drug transporters in human skin. In the present study, we upstream of ABCC3 (Rs: 20.323, P < 0.05). The reporter gene assay revealed evaluated the expression of ATP-binding cassette (ABC) and solute carrier a significant increase in transcriptional activity in the presence of CGI.
    [Show full text]
  • Whole-Exome Sequencing Identifies Novel Mutations in ABC Transporter
    Liu et al. BMC Pregnancy and Childbirth (2021) 21:110 https://doi.org/10.1186/s12884-021-03595-x RESEARCH ARTICLE Open Access Whole-exome sequencing identifies novel mutations in ABC transporter genes associated with intrahepatic cholestasis of pregnancy disease: a case-control study Xianxian Liu1,2†, Hua Lai1,3†, Siming Xin1,3, Zengming Li1, Xiaoming Zeng1,3, Liju Nie1,3, Zhengyi Liang1,3, Meiling Wu1,3, Jiusheng Zheng1,3* and Yang Zou1,2* Abstract Background: Intrahepatic cholestasis of pregnancy (ICP) can cause premature delivery and stillbirth. Previous studies have reported that mutations in ABC transporter genes strongly influence the transport of bile salts. However, to date, their effects are still largely elusive. Methods: A whole-exome sequencing (WES) approach was used to detect novel variants. Rare novel exonic variants (minor allele frequencies: MAF < 1%) were analyzed. Three web-available tools, namely, SIFT, Mutation Taster and FATHMM, were used to predict protein damage. Protein structure modeling and comparisons between reference and modified protein structures were performed by SWISS-MODEL and Chimera 1.14rc, respectively. Results: We detected a total of 2953 mutations in 44 ABC family transporter genes. When the MAF of loci was controlled in all databases at less than 0.01, 320 mutations were reserved for further analysis. Among these mutations, 42 were novel. We classified these loci into four groups (the damaging, probably damaging, possibly damaging, and neutral groups) according to the prediction results, of which 7 novel possible pathogenic mutations were identified that were located in known functional genes, including ABCB4 (Trp708Ter, Gly527Glu and Lys386Glu), ABCB11 (Gln1194Ter, Gln605Pro and Leu589Met) and ABCC2 (Ser1342Tyr), in the damaging group.
    [Show full text]